Skip to content

3SPHARMA

Active
Private limited companyfounded 2009active for 17 yearsHertogenlaan(LIN) 35, 3210 Lubbeek, BelgiumKBO/BCE: BE 0817.889.449
Summary

3SPHARMA has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €362,775 and a net result of €74,387. Equity is growing by about 27% per year across the filed financial years. Its solvency ranks better than 67% of 22,479 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Register details

Identification
Legal formPrivate limited company
Founded19-08-2009
Financial year end31-03
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0817889449
Also 9925:BE0817889449
Registered 27-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 22 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Lubbeekunit no. 2.180.498.632
1 permission
Apotheek (LM>3 maand) · since 06-08-2009

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Lubbeek · 1 establishment unit since 2009
registered office establishment The establishment unit on the map
Ground area
1,631 m²
Building footprint
199 m²
Building volume
1,407 m³
Parcel 24063A0003/00R003, Flanders · tallest building 28.0 m. Linked by address, not a title deed.
1 establishment unit
3SPHARMA
Hertogenlaan(LIN) 35, 3210 LubbeekRetail sale of pharmaceutical products
since 2009unit no. 2.180.498.632
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
24063A0003/00R003 Flanders 1,631 m² 1 · 199 m² 28.0 m · 1
How the parcels are linked
Good to know
The parcel matches the address exactly.